Press release
AI in Clinical Trials Market to Reach USD 4.11 Bn by 2029, emerging at a CAGR of 15.5 percent and forecast 2023-2029
AI in Clinical Trials Market
The findings presented in this report are backed by a rigorous research methodology, combining primary and secondary research. The scope of the study encompasses a detailed analysis validated through advanced algorithms and data gathered from diverse sources.
Request a Free Sample Copy or View Report Summary: https://www.maximizemarketresearch.com/request-sample/222597
What are AI in Clinical Trials Market Dynamics:
AI in Clinical Trials Market offers a substantial advantage by automating the time-consuming and resource-intensive tasks inherent in clinical trials. These tasks encompass data aggregation, analysis, cohort selection, and patient recruitment. For instance, AI algorithms excel in the meticulous examination of extensive patient data to pinpoint ideal candidates for clinical trials. As well as these algorithms can discern patient behavior patterns and offer trial design recommendations. AI-driven tools like Starmind expedite the journey to AI in Clinical Trials Market for research and development (R&D) initiatives by enhancing knowledge accessibility and fostering more efficient collaboration within organizations.
Get More Information Click Here: https://www.maximizemarketresearch.com/market-report/ai-in-clinical-trials-market/222597/
AI in Clinical Trials Market Regional Insights:
North America: Leading the AI integration, the United States spearheads the region's robust healthcare infrastructure and FDA's support for AI in clinical trials. Collaborations between pharmaceutical and tech giants drive innovation.
Europe: Nations like the UK, Germany, and France embrace rapid AI adoption, bolstered by strong pharmaceutical sectors and supportive regulatory frameworks.
Asia-Pacific: Emerging as a significant player, countries like China and India leverage AI to enhance clinical trial efficiency, while Japan offers opportunities with its advanced technology ecosystem.
Latin America: Gradually embracing AI, Brazil and Mexico witness growth through collaborations between local research institutions and global pharmaceutical companies.
Middle East and Africa: Experiencing nascent growth, countries like South Africa and the UAE invest in healthcare infrastructure and technology to drive AI adoption.
Request a Free Sample Copy or View Report Summary: https://www.maximizemarketresearch.com/request-sample/222597
What is AI in Clinical Trials Market Segmentation:
by Trial
Phase Phase I
Phase II
Phase III
by Target Therapeutic Area
Cardiovascular Disorders
CNS Disorders
Infectious Diseases
Metabolic Disorders
Oncological Disorders
Other Disorders
by Technology
Machine Learning
Natural Language processing
Deep Learning
Unspecified
by Application
Patient Recruitment
Data Analysis
Safety Monitoring
Drug Discovery
Personalized Medicine
by End-User
Pharmaceutical Companies
Research Institutes
CRO's
Hospitals
Others
Who are AI in Clinical Trials Market Key Players:
1. Euretos
2. Biosymetric
3. Unlearn.AI,Inc.
4. Exscientia
5. IMB Corporation
6. AiCure
7. Antidote Technologies
8. Deep 6 AI
9. Innoplexus
10. IQVIA
11. Median Technologies
12. Medidata
13. Mendel.ai
14. Phesi
15. Saama Technologies
16. Signant Health
17. Trials.ai
Request a Free Sample Copy or View Report Summary: https://www.maximizemarketresearch.com/request-sample/222597
Table of content for the AI in Clinical Trials Market includes:
Global AI in Clinical Trials Market: Research Methodology
Global AI in Clinical Trials Market: Executive Summary
Market Overview and Definitions
Introduction to the Global Market
Summary
Key Findings
Recommendations for Investors
Recommendations for Market Leaders
Recommendations for New Market Entry
3.Global AI in Clinical Trials Market: Competitive Analysis
MMR Competition Matrix
Market Structure by region
Competitive Benchmarking of Key Players
Consolidation in the Market
M&A by region
Key Developments by Companies
Market Drivers
Market Restraints
Market Opportunities
Market Challenges
Market Dynamics
PORTERS Five Forces Analysis
PESTLE
Regulatory Landscape by region
North America
Europe
Asia Pacific
Middle East and Africa
South America
COVID-19 Impact
More Related Reports:
Telecom IT Services Market https://www.maximizemarketresearch.com/market-report/global-telecom-it-services-market/8223/
Ball Bearing Market https://www.maximizemarketresearch.com/market-report/global-ball-bearing-market/22713/
Hazelnut market https://www.maximizemarketresearch.com/market-report/hazelnut-market/123229/
India Olive Oil Market https://www.maximizemarketresearch.com/market-report/india-olive-oil-market/38901/
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 444 West Lake Street, Floor 17,
Chicago, IL, 60606, USA.
✆ +1 800 507 4489
✆ +91 9607365656
🖂 sales@maximizemarketresearch.com
🌐 https://www.maximizemarketresearch.com
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of the majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI in Clinical Trials Market to Reach USD 4.11 Bn by 2029, emerging at a CAGR of 15.5 percent and forecast 2023-2029 here
News-ID: 3331492 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
Commercial Kitchen Appliances Market Poised for Robust Growth, Expected to Reach …
The global Commercial Kitchen Appliances Market, valued at US$ 101.65 billion in 2023, is witnessing strong momentum driven by the rapid expansion of the foodservice industry, technological innovation, and evolving consumer lifestyles. According to the latest market analysis, the industry is projected to grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2030, reaching nearly US$ 160.05 billion by the end of the forecast period.
Commercial kitchen…
E-Bike Market Poised for Robust Expansion, Projected to Reach USD 153.42 Billion …
The global E-Bike Market is entering a transformative growth phase, underpinned by accelerating demand for eco-friendly transportation, rapid advances in battery and motor technologies, and strong policy support for sustainable urban mobility. Valued at USD 60.65 Billion in 2024, the market is projected to expand at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2032, reaching nearly USD 153.42 Billion by 2032. As cities worldwide seek to…
Data Center Liquid Immersion Cooling Market Set for Rapid Expansion, Driven by H …
Data Center Liquid Immersion Cooling Market to Grow from USD 640.94 Million in 2023 to USD 3,340.83 Million by 2030, Registering a Robust CAGR of 26.6% (2024-2030)
The global Data Center Liquid Immersion Cooling Market is witnessing a transformative phase as data center operators worldwide seek advanced, energy-efficient cooling solutions to address rising power densities, sustainability mandates, and escalating operational costs. Valued at USD 640.94 million in 2023, the market…
Exosomes Market Forecast: USD 3,430.99 Million Opportunity by 2032
Exosomes Market size was valued at USD 423.2 Mn in 2024 and is expected to reach USD 3430.99 Mn by 2032, at a CAGR of 29.90
The global exosomes market is currently poised for explosive growth, fundamentally driven by the paradigm shift toward non-invasive diagnostics and the rising prominence of "liquid biopsies" in oncology. Once considered mere cellular waste, these extracellular vesicles are now recognized as critical mediators of intercellular communication,…
More Releases for Trial
Clinical Trial Investigative Site Network Market Clinical Trial Investigative Si …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trial Investigative Site Network Market - (By Therapeutic Areas (Oncology, Cardiology, CNS, Pain Management, Endocrine, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Sponsor, CRO)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Clinical Trial Investigative Site Network Market…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period.
Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to the…
Clinical Trial Logistics
Clinical Trial Logistics
16th to 17th May 2011, Marriott Regents Park, London, United Kingdom.
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials…
Clinical Trial Logistics
Announcing SMi's 5th annual…
Clinical Trial Logistics conference
16th and 17th May 2011, Central London, UK
www.smi-online.co.uk/2011logistics-london6.asp
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical…
